Related Experiment Video
Updated: Jul 16, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
Evidence for involvement of phosphatidylcholine-phospholipase C and protein kinase C in transforming growth
J Halstead1, K Kemp, R A Ignotz
1Department of Cell Biology, University of Massachusetts Medical Center, Worcester 01655, USA.
Abstract:
Transforming growth factor-beta (TGF-beta) is a multifunctional peptide that elicits a wide variety of responses in cells. TGF-beta binds to cell surface receptors that contain cytoplasmic serine/threonine kinase domains. Here we provide evidence that both phospholipase C and protein kinase C (PKC) are involved in the TGF-beta activation of transcription and luciferase expression from the p3TP-Lux plasmid. Down-regulation of PKC prevents TGF-beta 1 induction of luciferase expression. Staurosporin and Calphostin C, inhibitors of PKC, block the ability of TGF-beta 1 to initiate transcription of the luciferase gene. Further, D609, an inhibitor of phosphatidylcholine-phospholipase C (PC-PLC), and secondarily PKC also blocks TGF-beta 1-induced transcription of the transgene in A549 cells while the phosphatidylinositol-PLC pathway inhibitor U73122 is without effect. TGF-beta elevates steady-state mRNA levels for the endogenous PAI-1 and fibronectin genes. Treatment of cells with calphostin C or D609 prevents the TGF-beta-induced increase in these mRNAs. Together, these results suggest that PC-PLC and PKC are in a TGF-beta signaling pathway that results in elevated gene expression.
Insights
Transforming growth factor-beta (TGF-beta) signaling activates gene expression through phospholipase C and protein kinase C (PKC). Inhibiting these enzymes blocks TGF-beta
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Biochemistry
Background:
- Transforming growth factor-beta (TGF-beta) is a key signaling molecule regulating cellular functions.
- TGF-beta exerts its effects by binding to cell surface receptors with kinase domains.
- Understanding TGF-beta's downstream signaling is crucial for comprehending its diverse cellular responses.
Purpose of the Study:
- To investigate the role of phospholipase C and protein kinase C (PKC) in TGF-beta-induced gene transcription.
- To identify the specific phospholipase C isoform involved in the TGF-beta signaling pathway.
- To determine the impact of inhibiting PC-PLC and PKC on TGF-beta-mediated gene expression.
Main Methods:
- Utilized the p3TP-Lux plasmid to measure TGF-beta-induced luciferase expression.
- Employed PKC inhibitors (Staurosporin, Calphostin C) and a PC-PLC inhibitor (D609).
- Assessed mRNA levels of endogenous genes (PAI-1, fibronectin) using quantitative methods.
Main Results:
- Phospholipase C and PKC are integral to TGF-beta-induced transcription and luciferase expression.
- Down-regulation or inhibition of PKC significantly blocks TGF-beta 1-induced gene transcription.
- Inhibition of phosphatidylcholine-phospholipase C (PC-PLC) by D609, but not phosphatidylinositol-PLC by U73122, prevented TGF-beta 1-induced transcription.
- TGF-beta-induced increases in PAI-1 and fibronectin mRNA levels were abrogated by PC-PLC and PKC inhibition.
Conclusions:
- The study identifies a signaling pathway involving PC-PLC and PKC in TGF-beta-mediated gene expression.
- These findings elucidate key molecular players in TGF-beta signal transduction.
- The results suggest PC-PLC and PKC are essential for TGF-beta's transcriptional regulation of target genes.
More Related Videos
Related Concept Videos
Amplifying Signals via Second Messengers
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
IP3/DAG Signaling Pathway

